2Munce SE,Stewart DE.Gender differences in depression and chronic pain conditions in a National Epidemiologie Smwey[J].Psychoso- matics,2007,48 (5): 394-399.
4Mease PJ. Further strategies for treating fibromyalgia: the role of se- rotonin and norepinephrine reuptake inhibitors[J]. Am J Med, 2009, 122(12 Suppl):S44-55.
5IYENGAR S, WEBSTER AA, HEMRICK-LUECKE SK, et al. Efficacy of duloxetine, a potent and balanced serotonin-norepine- phrine inhibitor in persistent pain models in rats[J]. J Pharmacol Exp Ther, 2004, 311(2): 576-584.
6RABASSEDA X. Duloxetine-a new serotonin/noradrenaline reuptake inhibitor for the treatment of depression[J]. Drugs Today (Bare), 2004, 40 (9): 773-790.
7WONG DT, BYMASTER FP. Dual serotonin and noradrenaline uptake inhibitor class of antidepressants potential for greater efficacy or just hype?[J]. Prog Drug Res, 2002, 58 : 169-222.
8PERAHIA DG, PRITCHETT YL, DESAIAH D, et al. Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect?[J]. Int Clin Psychopharmacol, 2006, 21 (6) : 311-317.
9RASKIN J, PRITCHETT YL, WANG F, et al. A double-blind, randomized muhicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain [J]. Pain Med, 2005, 6(5) : 346-356.
10REN K, DUBNER R. Descending modulation in persistent pain : an update[J]. Pain, 2002, 100(1-2) : 1-6.
5Brown KW,Levy AR,Rosberger Z,et al. Psychological distress and cancer survival: a follow -up 10 years after diagnosis[J].Psy- chosom Med ,2003,65(4) :636-643.
6Chu SH, Lee YJ, Lee ES, et al. Current use of drugs affecting the central nervous system for chemotherapy-induced peripheral neu- ropathy in cancer patients: a systematic review [J]. Support Care Cancer, 2015,23 (2) :513-524.
7Smith EM1 ,Pang H,Cirrincione C,et al. Effect of duloxetine on pain ,function, and quality of life among patients with chemother- apy-induced painful peripheral neuropathy:a randomized clinical trial[J]. JAMA,2013,3,309(13) : 1359-1367.
8Marcus DA. Headache and chronic pain syndromes: the case- based guide to targeted assessment and treatment [ M]. Totowa. NJ : Humana Press, 2007 : 1-2.
9Galvez R. Variable use of opioid pharmacotherapy for chronicnoncaneer pain in Europe: causes and consequences[J]. J Pain Palliat Care Pharmacother, 2009,23(4) : 346-356.
